Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep:124:110632.
doi: 10.1016/j.exger.2019.110632. Epub 2019 Jun 13.

Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses

Affiliations

Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses

Stephen N Crooke et al. Exp Gerontol. 2019 Sep.

Abstract

Immunosenescence contributes to a decreased capacity of the immune system to respond effectively to infections or vaccines in the elderly. The full extent of the biological changes that lead to immunosenescence are unknown, but numerous cell types involved in innate and adaptive immunity exhibit altered phenotypes and function as a result of aging. These manifestations of immunosenescence at the cellular level are mediated by dysregulation at the genetic level, and changes throughout the immune system are, in turn, propagated by numerous cellular interactions. Environmental factors, such as nutrition, also exert significant influence on the immune system during aging. While the mechanisms that govern the onset of immunosenescence are complex, systems biology approaches allow for the identification of individual contributions from each component within the system as a whole. Although there is still much to learn regarding immunosenescence, systems-level studies of vaccine responses have been highly informative and will guide the development of new vaccine candidates, novel adjuvant formulations, and immunotherapeutic drugs to improve vaccine responses among the aging population.

Keywords: Adjuvants; Aging; Immunity; Immunosenescence; Senolytics; Systems biology; Vaccinology.

PubMed Disclaimer

Conflict of interest statement

COMPETING INTERESTS

Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co. Inc., Avianax, Adjuvance, Valneva, Medicago, Sanofi Pasteur, GlaxoSmithKline, and Emergent Biosolutions. Drs. Poland and Ovsyannikova hold patents related to vaccinia and measles peptide vaccines. Dr. Kennedy holds a patent related to vaccinia peptide vaccines. Dr. Kennedy has received research funding from Merck Research Laboratories to study waning immune responses to mumps vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. All other authors declare no competing interests.

Figures

Figure 1.
Figure 1.. Immune cell populations and the effects of immunosenescence on cellular function.
Arrows denote crosstalk/signaling between cell populations, illustrating the potential for dysfunction in a single population to affect the function of numerous other cell subsets. Innate immune cells (neutrophils, macrophages/monocytes, dendritic cells, NK cells) are all involved with signaling and recruitment of other innate cell populations during the early phases of an immune response. Macrophages and dendritic cells bridge the gap from innate to adaptive immunity via antigen presentation and stimulatory signaling to cognate T-cells, and disruption in either of these functions can drastically compromise adaptive responses. Helper T-cells are critical for subsequent development of robust B-cell antibody responses, further illustrating how dysfunction among cells at both the innate and adaptive level can affect the overall outcomes of an immune response.
Figure 2.
Figure 2.. Genetic regulatory mechanisms affected by immunosenescence.
Regulation of cellular function is often mediated by changes at the genetic level. Covalent modifications on histone tails modulate the accessibility of DNA for transcription, methylation of CpG sequences in promoter regions can affect transcription factor binding, and miRNA expression can modulate gene silencing through a number of different mechanisms at the post-transcriptional level. All of these have been shown to be differentially regulated to some capacity with aging and associated with changes in immune cell function.

References

    1. Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Immunology Letters. 2014;162(1 Pt B):346–53. doi:10.1016/j.imlet.2014.06.006. - DOI - PubMed
    1. Jaul E, Barron J. Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Front Public Health. 2017;5:335. doi:10.3389/fpubh.2017.00335. - DOI - PMC - PubMed
    1. Buford TW. Hypertension and aging. Ageing Res Rev. 2016;26:96–111. doi:10.1016/j.arr.2016.01.007. - DOI - PMC - PubMed
    1. Niccoli T, Partridge L. Ageing as a risk factor for disease. Current biology: CB. 2012;22(17):R741–52. doi:10.1016/j.cub.2012.07.024. - DOI - PubMed
    1. Pera A, Campos C, Lopez N, Hassouneh F, Alonso C, Tarazona R et al. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas. 2015. doi:10.1016/j.maturitas.2015.05.004. - DOI - PubMed

Publication types